What laboratory tests should be ordered to evaluate an older adult presenting with confusion and dementia?

Laboratory Evaluation for Confusion and Dementia

All older adults presenting with confusion and dementia should receive a comprehensive Tier 1 laboratory panel that includes: CBC with differential, complete metabolic panel (Chem-20 with renal/hepatic function, electrolytes, glucose, calcium, magnesium, phosphate), TSH, vitamin B12, homocysteine, CRP, and ESR. 1

Core Tier 1 Laboratory Tests (Obtain in All Patients)

The 2025 Alzheimer's Association guidelines provide the most current, evidence-based approach with Strength of Recommendation A for routine laboratory testing 1:

Complete Blood Count and Metabolic Panel

• CBC with differential to identify anemia, infection, or hematologic disorders that may contribute to cognitive symptoms 1
• Complete metabolic panel (Chem-20) including:
  • Renal function (creatinine, BUN) 1
  • Hepatic function (AST, ALT, alkaline phosphatase, bilirubin) 1
  • Electrolytes (sodium, potassium, chloride, bicarbonate) 1
  • Glucose (to detect hypo- or hyperglycemia) 1
  • Calcium, magnesium, and phosphate 1

Endocrine and Vitamin Assessment

• Thyroid-stimulating hormone (TSH) - hypothyroidism is common in older adults and can cause neuropsychiatric symptoms and cognitive decompensation 1, 2
• Vitamin B12 level - deficiency is prevalent in the elderly and treatable, with potential for symptom improvement 1, 2
• Homocysteine level - elevated homocysteine indicates functional B12 deficiency that may not be detected by B12 levels alone 1

Inflammatory Markers

• C-reactive protein (CRP) 1
• Erythrocyte sedimentation rate (ESR) 1

Rationale for This Comprehensive Approach

These tests identify common comorbid conditions that rarely cause dementia primarily but frequently contribute to cognitive or behavioral symptoms. 1 The multi-tiered approach balances individualized risk factors while ensuring no treatable conditions are missed 1. While truly reversible dementia is rare (approximately 1% of cases), treatment of contributing medical conditions—particularly thyroid dysfunction, B12 deficiency, and metabolic derangements—can improve symptoms and quality of life 1, 3.

Additional Testing Based on Clinical Context

Syphilis Screening

• Only order when clinical suspicion exists - routine screening is not justified in all dementia patients 2
• Consider in patients with specific risk factors or atypical presentations 2

Structural Neuroimaging

• Brain MRI without contrast is standard of care (or CT if MRI contraindicated or unavailable) 1
• Obtain in almost all patients to exclude non-AD/ADRD conditions (tumors, infarcts, subdural hematomas) and identify regional atrophy patterns 1

Critical Clinical Integration Points

Laboratory results must never be interpreted in isolation. 1 Integration with the following is essential:

• Thorough medical history including medication review (particularly anticholinergics, sedatives) 1, 4
• Assessment for delirium (acute change, fluctuating consciousness, inattention) which can complicate underlying dementia 1
• Validated cognitive testing (Mini-Mental State Examination, Montreal Cognitive Assessment, or brief screening tools) 1, 5, 4
• Depression screening 4
• Evaluation of comorbidities that may influence biomarker interpretation (obesity, chronic kidney disease) 1

Common Pitfalls to Avoid

• Do not skip homocysteine testing - B12 levels alone may miss functional deficiency 1
• Do not order excessive tests without clinical indication - the yield of additional testing beyond the Tier 1 panel is low without specific clinical suspicion 3, 2
• Do not forget to assess for medication-induced cognitive impairment - particularly anticholinergics, benzodiazepines, and polypharmacy 1, 4
• Do not overlook subsyndromal or hypoactive delirium - this atypical presentation is more common in older adults and carries higher mortality risk 1